Trial intelligence / Profile preview

Gabapentin vs Carbamazepine for Neuropathic Pain in Guillain-Barré Syndrome

NCT07907406Completed

Sponsor
Lahore General Hospital
Start
Jan 2026
Primary completion
Jun 2026
Countries
1
01

Overview

Randomised trial of gabapentin in neuropathic pain (2 arms), sponsored by Lahore General Hospital. Primary endpoint: Mean Neuropathic Pain Score at 7 days. Started Jan 2026; status: completed.

02

Drugs

gabapentin
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT07907406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07907406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call